CXCL9 and cancer: Baseline expression levels of CXCL9, CXCL10, and CXCL11 were relatively low and comparable between MTAP-WT and MTAP-KO CL1–0 and 786–0 cancer cells, as well as between CL1–5 Mock and MTAP-expressing cells (Figures 2B–D).